Expression of IL4 Induced Gene 1 in Patients With Cutaneous Melanoma: Value in Prognosis and/or in Predictive Response to Immune Checkpoint Inhibitors
Clinical trial NCT04253080 · COMPLETED
Trial details
- NCT number
- NCT04253080
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-12
- Primary completion
- 2024-11-04
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.